Abstract
<p>Fig. S1 K562 cells were treated with morin (25 μM) and different concentrations of Imatinib (0-1 μM) for 48 h, respectively; Fig.S2 K562 cells were treated with morin (25 μM) and Imatinib (0.1 μM) or not then cell apoptosis was determined by Annexin V-FITC/PI staining; Fig. S3 K562 cells were transfected with miR-188-5p mimic or mimic-NC and then incubated with the different concentrations (0-1 μM) of Imatinib in the presence or absence of 25 μM morin; Fig. S4 K562 cells were transfected with miR-188-5p mimic, or mimic-NC, and then treated with Imatinib (0.1 μM) and combination with morin (25 μM) or not for 48 h.</p>
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
